APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients

A. Barberá; N. Lorenzo; Y. Mazola; V. Falcón; A.M. Torres; M.I. Hernández; M.V. Hernández; B. Margry; A.M. de Groot; J.A.G. van Roon; R. van der Zee; F. Broere; W. van Eden; G. Padrón; M.D.C. Domínguez

doi:10.1016/j.intimp.2013.10.010

APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients

A. Barberá
, N. Lorenzo
, Y. Mazola
, V. Falcón
, A.M. Torres
, M.I. Hernández
, M.V. Hernández
, B. Margry
, A.M. de Groot
, J.A.G. van Roon
, R. van der Zee
, F. Broere
, W. van Eden
, G. Padrón
, M.D.C. Domínguez

extern
University Medical Center Utrecht

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1075-1083
Number of pages	9
Journal	International Immunopharmacology
Volume	17
Issue number	4
DOIs	https://doi.org/10.1016/j.intimp.2013.10.010
Publication status	Published - 2013

Access to Document

10.1016/j.intimp.2013.10.010

http://www.ncbi.nlm.nih.gov/pubmed/24177275

Embargoed Document

A
Final published version, 906 KB
Embargo ends: 01/01/2050 00:00 CET

Cite this

Barberá, A., Lorenzo, N., Mazola, Y., Falcón, V., Torres, A. M., Hernández, M. I., Hernández, M. V., Margry, B., de Groot, A. M., van Roon, J. A. G., van der Zee, R., Broere, F., van Eden, W., Padrón, G., & Domínguez, M. D. C. (2013). APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients. International Immunopharmacology, 17(4), 1075-1083. https://doi.org/10.1016/j.intimp.2013.10.010

@article{5405d79ad130413cb00c93dc1b312fb4,

title = "APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients",

author = "A. Barber{\'a} and N. Lorenzo and Y. Mazola and V. Falc{\'o}n and A.M. Torres and M.I. Hern{\'a}ndez and M.V. Hern{\'a}ndez and B. Margry and \{de Groot\}, A.M. and \{van Roon\}, J.A.G. and \{van der Zee\}, R. and F. Broere and \{van Eden\}, W. and G. Padr{\'o}n and M.D.C. Dom{\'i}nguez",

year = "2013",

doi = "10.1016/j.intimp.2013.10.010",

language = "Undefined/Unknown",

volume = "17",

pages = "1075--1083",

journal = "International Immunopharmacology",

issn = "1567-5769",

publisher = "Elsevier BV",

number = "4",

}

Barberá, A, Lorenzo, N, Mazola, Y, Falcón, V, Torres, AM, Hernández, MI, Hernández, MV, Margry, B, de Groot, AM, van Roon, JAG, van der Zee, R, Broere, F , van Eden, W, Padrón, G & Domínguez, MDC 2013, 'APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients', International Immunopharmacology, vol. 17, no. 4, pp. 1075-1083. https://doi.org/10.1016/j.intimp.2013.10.010

APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients. / Barberá, A.; Lorenzo, N.; Mazola, Y. et al.
In: International Immunopharmacology, Vol. 17, No. 4, 2013, p. 1075-1083.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients

AU - Barberá, A.

AU - Lorenzo, N.

AU - Mazola, Y.

AU - Falcón, V.

AU - Torres, A.M.

AU - Hernández, M.I.

AU - Hernández, M.V.

AU - Margry, B.

AU - de Groot, A.M.

AU - van Roon, J.A.G.

AU - van der Zee, R.

AU - Broere, F.

AU - van Eden, W.

AU - Padrón, G.

AU - Domínguez, M.D.C.

PY - 2013

Y1 - 2013

U2 - 10.1016/j.intimp.2013.10.010

DO - 10.1016/j.intimp.2013.10.010

M3 - Article

SN - 1567-5769

VL - 17

SP - 1075

EP - 1083

JO - International Immunopharmacology

JF - International Immunopharmacology

IS - 4

ER -